Published in Br J Dermatol on February 01, 2009
Sensing the environment: regulation of local and global homeostasis by the skin's neuroendocrine system. Adv Anat Embryol Cell Biol (2012) 2.99
Key role of CRF in the skin stress response system. Endocr Rev (2013) 1.77
Steroidogenesis in the skin: implications for local immune functions. J Steroid Biochem Mol Biol (2013) 1.71
Cutaneous hypothalamic-pituitary-adrenal axis homolog: regulation by ultraviolet radiation. Am J Physiol Endocrinol Metab (2011) 1.58
BuShenYiQi granule inhibits atopic dermatitis via improving central and skin Hypothalamic-Pituitary-Adrenal axis function. PLoS One (2015) 1.39
Substance P (SP) induces expression of functional corticotropin-releasing hormone receptor-1 (CRHR-1) in human mast cells. J Invest Dermatol (2011) 1.03
On the role of skin in the regulation of local and systemic steroidogenic activities. Steroids (2015) 1.01
Emerging role of alternative splicing of CRF1 receptor in CRF signaling. Acta Biochim Pol (2010) 0.97
Putative role of HIF transcriptional activity in melanocytes and melanoma biology. Dermatoendocrinol (2013) 0.92
"Sebocytes' makeup": novel mechanisms and concepts in the physiology of the human sebaceous glands. Pflugers Arch (2011) 0.87
Neurotensin and CRH interactions augment human mast cell activation. PLoS One (2012) 0.82
Increased serum CRH levels with decreased skin CRHR-1 gene expression in psoriasis and atopic dermatitis. J Allergy Clin Immunol (2012) 0.80
Stress triggers coronary mast cells leading to cardiac events. Ann Allergy Asthma Immunol (2013) 0.80
On the role of environmental humidity on cortisol production by epidermal keratinocytes. Exp Dermatol (2014) 0.79
Elevated serum neurotensin and CRH levels in children with autistic spectrum disorders and tail-chasing Bull Terriers with a phenotype similar to autism. Transl Psychiatry (2014) 0.78
Cutaneous Glucocorticoidogenesis and Cortisol Signaling Are Defective in Psoriasis. J Invest Dermatol (2017) 0.75
Inhibiting interleukin-18 production through the mitogen-activated protein kinase pathway, a potential role of corticotropin-releasing hormone in chronic plaque psoriasis. Inflammation (2015) 0.75
Physiology and neurobiology of stress and adaptation: central role of the brain. Physiol Rev (2007) 11.15
Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin. Science (1981) 9.64
The concepts of stress and stress system disorders. Overview of physical and behavioral homeostasis. JAMA (1992) 6.96
The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. N Engl J Med (1995) 6.17
Melanin pigmentation in mammalian skin and its hormonal regulation. Physiol Rev (2004) 5.89
Identification of urocortin III, an additional member of the corticotropin-releasing factor (CRF) family with high affinity for the CRF2 receptor. Proc Natl Acad Sci U S A (2001) 3.23
Physiology and pharmacology of corticotropin-releasing factor. Pharmacol Rev (1991) 3.07
Corticotropin releasing hormone and proopiomelanocortin involvement in the cutaneous response to stress. Physiol Rev (2000) 2.98
Urocortin II: a member of the corticotropin-releasing factor (CRF) neuropeptide family that is selectively bound by type 2 CRF receptors. Proc Natl Acad Sci U S A (2001) 2.87
Cloning and characterization of a functionally distinct corticotropin-releasing factor receptor subtype from rat brain. Proc Natl Acad Sci U S A (1995) 2.70
Human hair follicles display a functional equivalent of the hypothalamic-pituitary-adrenal axis and synthesize cortisol. FASEB J (2005) 2.23
The molecular mechanisms underlying the regulation of the biological activity of corticotropin-releasing hormone receptors: implications for physiology and pathophysiology. Endocr Rev (2006) 2.08
Corticotropin releasing factor receptors and their ligand family. Ann N Y Acad Sci (1999) 2.04
Cutaneous expression of corticotropin-releasing hormone (CRH), urocortin, and CRH receptors. FASEB J (2001) 1.74
Differential expression of HPA axis homolog in the skin. Mol Cell Endocrinol (2006) 1.72
Autocrine or paracrine inflammatory actions of corticotropin-releasing hormone in vivo. Science (1991) 1.70
Modulation of stress-induced ACTH release by corticotropin-releasing factor, catecholamines and vasopressin. Nature (1983) 1.64
CRH stimulation of corticosteroids production in melanocytes is mediated by ACTH. Am J Physiol Endocrinol Metab (2004) 1.64
Physiology, pharmacology, and therapeutic relevance of urocortins in mammals: ancient CRF paralogs. Front Neuroendocrinol (2006) 1.60
Alternative splicing of CRH-R1 receptors in human and mouse skin: identification of new variants and their differential expression. FASEB J (2001) 1.59
Mast cells as targets of corticotropin-releasing factor and related peptides. Trends Pharmacol Sci (2004) 1.50
Differential expression of a cutaneous corticotropin-releasing hormone system. Endocrinology (2003) 1.46
Potent, structurally constrained agonists and competitive antagonists of corticotropin-releasing factor. Proc Natl Acad Sci U S A (1995) 1.45
Corticotropin releasing hormone and the skin. Front Biosci (2006) 1.45
CRH stimulates POMC activity and corticosterone production in dermal fibroblasts. J Neuroimmunol (2005) 1.42
Melanocortin receptor ligands: new horizons for skin biology and clinical dermatology. J Invest Dermatol (2006) 1.41
CRH functions as a growth factor/cytokine in the skin. J Cell Physiol (2006) 1.38
Inhibition of melanogenesis as an adjuvant strategy in the treatment of melanotic melanomas: selective review and hypothesis. Anticancer Res (1999) 1.29
Corticotropin-releasing hormone: an autocrine hormone that promotes lipogenesis in human sebocytes. Proc Natl Acad Sci U S A (2002) 1.22
A nervous breakdown in the skin: stress and the epidermal barrier. J Clin Invest (2007) 1.16
Characterization of a ultraviolet B-induced corticotropin-releasing hormone-proopiomelanocortin system in human melanocytes. Mol Endocrinol (2006) 1.16
Proopiomelanocortin (POMC), the ACTH/melanocortin precursor, is secreted by human epidermal keratinocytes and melanocytes and stimulates melanogenesis. FASEB J (2007) 1.12
Corticotropin-releasing hormone stimulates NF-kappaB in human epidermal keratinocytes. J Endocrinol (2004) 1.10
Corticotropin-releasing hormone induces skin vascular permeability through a neurotensin-dependent process. Proc Natl Acad Sci U S A (2006) 1.10
Urocortins: emerging metabolic and energy homeostasis perspectives. Trends Endocrinol Metab (2008) 1.08
Regulation of the HPA axis by cytokines. Brain Behav Immun (1995) 1.08
Pleiotropic effects of corticotropin releasing hormone on normal human skin keratinocytes. In Vitro Cell Dev Biol Anim (2001) 1.07
Corticotropin-releasing hormone in humans. Endocr Rev (1992) 1.06
Corticotropin releasing hormone and related peptides can act as bioregulatory factors in human keratinocytes. In Vitro Cell Dev Biol Anim (2000) 1.04
The role of corticotropin-releasing hormone in immune-mediated cutaneous inflammatory disease. Exp Dermatol (2006) 1.01
Corticotropin-releasing hormone affects cytokine production in human HaCaT keratinocytes. Life Sci (2002) 0.99
Involvement of the corticotropin-releasing hormone system in the pathogenesis of acne vulgaris. Br J Dermatol (2008) 0.96
CRH inhibits NF-kappa B signaling in human melanocytes. Peptides (2006) 0.96
CRH mediates inflammation induced by lipopolysaccharide in human adult epidermal keratinocytes. J Invest Dermatol (2006) 0.94
Regulation of corticotropin-releasing hormone type 2 receptors by multiple promoters and alternative splicing: identification of multiple splice variants. Mol Endocrinol (2002) 0.93
Modulation of the human hair follicle pigmentary unit by corticotropin-releasing hormone and urocortin peptides. FASEB J (2006) 0.90
Corticotropin-releasing hormone skin signaling is receptor-mediated and is predominant in the sebaceous glands. Horm Metab Res (2007) 0.89
Constrained corticotropin-releasing factor (CRF) agonists and antagonists with i-(i+3) Glu-Xaa-DXbb-Lys bridges. J Med Chem (1998) 0.79
What are melanocytes really doing all day long...? Exp Dermatol (2009) 1.65
Production and release of proopiomelanocortin (POMC) derived peptides by human melanocytes and keratinocytes in culture: regulation by ultraviolet B. Biochim Biophys Acta (1996) 1.39
Vitiligo pathogenesis: autoimmune disease, genetic defect, excessive reactive oxygen species, calcium imbalance, or what else? Exp Dermatol (2008) 1.39
UV light and MSH receptors. Ann N Y Acad Sci (1999) 1.09
Pleiotropic effects of corticotropin releasing hormone on normal human skin keratinocytes. In Vitro Cell Dev Biol Anim (2001) 1.07
What are subcutaneous adipocytes really good for? Exp Dermatol (2007) 1.06
Mast cell involvement in murine hair growth. Dev Biol (1994) 1.06
What's the use of generating melanin? Exp Dermatol (1999) 1.04
Oncostatic effects of the indole melatonin and expression of its cytosolic and nuclear receptors in cultured human melanoma cell lines. Int J Oncol (2006) 1.02
Melatonin increases survival of HaCaT keratinocytes by suppressing UV-induced apoptosis. J Pineal Res (2006) 1.01
Modification of melanogenesis in cultured human melanoma cells. In Vitro Cell Dev Biol Anim (2000) 1.00
Hair cycle-dependent expression of corticotropin-releasing factor (CRF) and CRF receptors in murine skin. FASEB J (1998) 0.99
Steroidogenesis in the human skin: 21-hydroxylation in cultured keratinocytes. J Steroid Biochem Mol Biol (2001) 0.99
Inhibition of mouse melanoma cell proliferation by corticotropin-releasing hormone and its analogs. Anticancer Res (2001) 0.98
Is alopecia areata an autoimmune-response against melanogenesis-related proteins, exposed by abnormal MHC class I expression in the anagen hair bulb? Yale J Biol Med (1995) 0.97
Effect of CRF and related peptides on calcium signaling in human and rodent melanoma cells. FEBS Lett (1998) 0.97
Skin histoculture assay for studying the hair cycle. In Vitro Cell Dev Biol (1993) 0.95
Spatiotemporal expression, distribution, and processing of POMC and POMC-derived peptides in murine skin. J Histochem Cytochem (2000) 0.93
Production of POMC, CRH-R1, MC1, and MC2 receptor mRNA and expression of tyrosinase gene in relation to hair cycle and dexamethasone treatment in the C57BL/6 mouse skin. J Invest Dermatol (1997) 0.93
Melatonin maintains mitochondrial membrane potential and attenuates activation of initiator (casp-9) and effector caspases (casp-3/casp-7) and PARP in UVR-exposed HaCaT keratinocytes. J Pineal Res (2007) 0.92
The fate of hair follicle melanocytes during the hair growth cycle. J Investig Dermatol Symp Proc (1999) 0.91
Identification and characterization of two isozymic forms of arylamine N-acetyltransferase in Syrian hamster skin. J Invest Dermatol (1993) 0.90
Ultraviolet B and melanocyte-stimulating hormone (MSH) stimulate mRNA production for alpha MSH receptors and proopiomelanocortin-derived peptides in mouse melanoma cells and transformed keratinocytes. J Invest Dermatol (1995) 0.89
Cutaneous immunomodulation and coordination of skin stress responses by alpha-melanocyte-stimulating hormone. Ann N Y Acad Sci (1998) 0.88
Choriocarcinoma presenting as a cutaneous metastasis. J Cutan Pathol (1995) 0.87
The proopiomelanocortin system in cutaneous neuroimmunomodulation. An introductory overview. Ann N Y Acad Sci (1999) 0.86
The skin POMC system (SPS). Leads and lessons from the hair follicle. Ann N Y Acad Sci (1999) 0.84
Down-regulation of the expression of O-acetyl-GD3 by the O-acetylesterase cDNA in hamster melanoma cells: effects on cellular proliferation, differentiation, and melanogenesis. J Neurochem (1999) 0.84
Microassay of phosphate provides a general method for measuring the activity of phosphatases using physiological, nonchromogenic substrates such as lysophosphatidic acid. Anal Biochem (2001) 0.83
Identification of beta-endorphin, alpha-MSH and ACTH peptides in cultured human melanocytes, melanoma and squamous cell carcinoma cells by RP-HPLC. Exp Dermatol (1998) 0.83
Can some melanotropins modulate keratinocyte proliferation? J Invest Dermatol (1991) 0.82
Developmentally regulated expression of alpha-MSH and MC-1 receptor in C57BL/6 mouse skin suggests functions beyond pigmentation. Ann N Y Acad Sci (1999) 0.82
Cervical posterior rhizotomy for reducing spasticity in cerebral palsy. J Neurosurg (1973) 0.81
L-dopa binding sites in rodent melanoma cells. Biochim Biophys Acta (1992) 0.80
Endocannabinoid crosstalk between placenta and maternal fat in a baboon model (Papio spp.) of obesity. Placenta (2013) 0.80
What controls melanogenesis? Exp Dermatol (1998) 0.79
Characterization of a hamster melanoma-associated ganglioside antigen as 7-O-acetylated disialoganglioside GD3. J Lipid Res (1993) 0.79
Experimental ruthenium plaque therapy of amelanotic and melanotic melanomas in the hamster eye. Melanoma Res (2000) 0.78
What is the most promising strategy for the treatment of metastasizing melanoma? Exp Dermatol (2000) 0.78
Melanocytic matricoma: a report of two cases of a new entity. Am J Dermatopathol (1999) 0.77
On the putative mechanism of induction and regulation of melanogenesis by L-tyrosine. Acta Derm Venereol (1991) 0.77
Identification and measurement of beta-endorphin levels in the skin during induced hair growth in mice. Biochim Biophys Acta (1997) 0.77
Scalp nodule on a middle-aged woman. Clin Exp Dermatol (2011) 0.77
Re: G.P. Studzinski and D.C. Moore, sunlight--can it prevent as well as cause cancer? Cancer Res., 55: 4014-4022, 1995. Cancer Res (1996) 0.75
Dermatofibrosarcoma protuberans can induce epidermal hyperplasia that is inversely related to its proximity to the epidermis. Am J Dermatopathol (1998) 0.75
Transplantable melanomas in gerbils (Meriones unguiculatus). I. Origin, morphology and growth rate. Anticancer Res (1996) 0.75
Glycosphingolipids in Bomirski transplantable melanomas in hamsters. Cancer Res (1989) 0.75
Differential temporal and spatial expression of POMC mRNA and of the production of POMC peptides during the murine hair cycle. Ann N Y Acad Sci (1999) 0.75